Login to Your Account



Pharma: Other News To Note


Tuesday, May 1, 2012
• Merck & Co. Inc., of Whitehouse Station, N.J., said the District Court for the District of New Jersey ruled in its favor in two jointly related patent infringement suits against Mylan Pharmaceuticals Inc., of Pittsburgh, upholding Merck's patent on Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription